AP-HM, Centre de Néphrologie et Transplantation Rénale, CHU de la Conception, AP-HM, Marseille, France.
Aix-Marseille Univ, C2VN, INSERM, INRAE, Marseille, France.
BMC Med Genet. 2020 Jun 26;21(1):137. doi: 10.1186/s12881-020-01071-5.
Fabry disease (FD) is an X-linked lysosomal storage disorder due to deficient alpha-galactosidase activity leading to intracellular glycosphingolipid accumulation. Multiple variants have been reported in the GLA gene coding for alpha-galactosidase, and the question of the pathogenicity of rare variants needs to be addressed, especially in patients with mild phenotypes.
The patient, a 37-year-old female, presented with a persistent proteinuria after an otherwise uncomplicated first pregnancy. Renal biopsy showed both mild mesangial IgA deposits, and a striking vacuolization of podocytes and tubular cells consistent with Fabry disease. On electron microscopy, discrete but characteristic pseudo-myelinic lamellar inclusions were observed in the podocytes' lysosomes. A more detailed physical examination revealed an angiokeratoma, and medical history ancient acroparesthesia. There was no cardiac or cerebral involvement of Fabry disease on magnetic resonance imaging. While blood enzymatic activity of alpha-ga lactosidase was normal in this patient, lysoGb3 was elevated (3 N), and a rare heterozygous variant called c.610 T > C was documented in GLA gene. The patient was treated with an ACE inhibitor, with a rapid decrease in proteinuria. After a 5-year follow-up, her renal function has remained normal, with mild proteinuria, and normal cardiac echography.
We report and phenotypically describe the first case of a Fabry disease female patient carrying the GLA c.610 T > C variant associated with a renal-predominant clinical presentation.
法布里病(FD)是一种 X 连锁溶酶体贮积病,由于缺乏α-半乳糖苷酶活性导致细胞内糖鞘脂积累。在编码α-半乳糖苷酶的 GLA 基因中已经报道了多种变体,需要解决罕见变体的致病性问题,特别是在具有轻度表型的患者中。
患者,一名 37 岁女性,在首次妊娠后出现持续性蛋白尿,其他方面均无异常。肾活检显示系膜 IgA 沉积轻度,足细胞和肾小管细胞空泡化明显,符合法布里病。在电子显微镜下,在足细胞的溶酶体中观察到离散但特征性的假髓鞘层状内含物。更详细的体格检查发现存在血管角皮瘤,并有古发性肢端感觉异常病史。磁共振成像未发现法布里病的心脏或脑部受累。虽然该患者的血液α-半乳糖苷酶酶活性正常,但溶酶体 Gb3 升高(3N),并在 GLA 基因中记录到一种罕见的杂合变异,称为 c.610T > C。该患者接受了 ACE 抑制剂治疗,蛋白尿迅速减少。经过 5 年的随访,她的肾功能保持正常,仅有轻度蛋白尿和正常的心脏超声。
我们报告并表型描述了首例携带 GLA c.610T > C 变异的法布里病女性患者,其临床表现为肾优势型。